These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Antiarrhythmic agents. Receptor hypothesis explains mechanisms of action].
    Author: Bjørnstad H, Refsum H.
    Journal: Tidsskr Nor Laegeforen; 1991 Oct 30; 111(26):3187-9. PubMed ID: 1658976.
    Abstract:
    Antiarrhythmic drugs are usually classified according to Vaughan Williams' classification I-IV. Class I includes the membrane stabilizers, class II includes the beta-blockers, drugs in class III lengthen the cardiac action potential and refractory period and class IV includes the calcium blockers. The effect of most antiarrhythmic drugs changes with heart rate and the level of myocardial depolarization, and these changes in effect can be explained by the modulated receptor hypothesis. Most class I antiarrhythmic drugs have greatest antiarrhythmic effect during periods of fast heart rate and in depolarized ischemic myocardium, and this might be attributed to greater affinity of the drugs for open or inactivated sodium channels. Most class III antiarrhythmic drugs have greatest effect during periods of slow heart rates, which may be attributed to greater affinity for closed potassium channels.
    [Abstract] [Full Text] [Related] [New Search]